Xuanbinh Pham, MD
Vascular Surgery · Orange, CANPI 1003164112
Payments from drug & device makers
Across 91 payments — averaging $303.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- Angiodynamics, Inc.$8K
- W. L. Gore & Associates, Inc.$1K
- Penumbra, Inc.$863
- Abbott$345
- Cook Medical LLC$303
- plus $1K from 15 others
What the payments were for
- Grants$14,88654%
- Travel & lodging$1,1304%
- Food & beverage$3,11211%
- Education$2621%
- Other$8,26730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 26 | $15,281 |
| Angiodynamics, Inc. | 3 | $8,293 |
| W. L. Gore & Associates, Inc. | 8 | $1,345 |
| Penumbra, Inc. | 13 | $863 |
| Abbott | 10 | $345 |
| Cook Medical LLC | 1 | $303 |
| Silk Road Medical, Inc. | 6 | $241 |
| Koya Medical, Inc. | 1 | $238 |
| Reflow Medical Inc | 5 | $191 |
| Laminate Medical Technologies Inc. | 1 | $103 |
| Mimedx Group, Inc. | 4 | $102 |
| Terumo Medical Corporation | 2 | $58 |
| Inari Medical, Inc. | 2 | $58 |
| Baxter Healthcare | 1 | $48 |
| Johnson & Johnson | 1 | $46 |
| Imperative Care, Inc | 2 | $41 |
| Microtransponder, Inc. | 1 | $23 |
| Shockwave Medical, Inc | 1 | $22 |
| Solventum Corporation | 1 | $20 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,656 in reported general payments places this provider in the 80th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $26,526 |
| ClopidogrelClopidogrel Bisulfate | 43 | $397 |
| Cilostazol | 14 | $374 |
| Oxycodone Hcl | 23 | $41 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Orange
- Anthony ChauOrange$226K
- Roy FujitaniOrange$86K
- Nii-Kabu KabuteyOrange$71K
- Venita ChandraPalo Alto$947K
- Leigh Ann ObanionFresno$932K
- Sukgu HanLos Angeles$765K
- Mahmoud Malasla Jolla$508K
- Son DuongFountain Valley$503K
- Leo FongClovis$496K
- Jason LeePalo Alto$403K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.